Variables | Tissue | Saliva | ||||
---|---|---|---|---|---|---|
Controls (n = 92) | HNSCC (n = 189) | p | Controls (n = 108) | HNSCC n = (86) | p | |
Age (years, mean ± SD) | 54.98 ± 17.63 | 63.23 ± 11.58 | < 0.0001 | 53.77 ± 16.04 | 61.07 ± 9.66 | 0.0001 |
Gender | Â | Â | 0.38 | Â | Â | 0.20 |
 Male (%) | 65.2%(60/92) | 70.1% (131/187) |  | 69.4% (75/108) | 77.9% (67/86) |  |
 Female (%) | 34.8%(32/92) | 29.9% (56/187) |  | 30.6% (33/108) | 22.1% (19/86) |  |
Smoking status | Â | Â | 0.35 | Â | Â | 0.25 |
 Never | 25.6% (23/90) | 22.4% (37/165) |  | 26.9% (29/108) | 19.8% (17/86) |  |
 Current | 21.1% (19/90) | 30.3% (50/165) |  | 16.7% (18/108) | 24.4% (21/86) |  |
 Ex-smoker | 53.3%(48/90) | 47.3% (78//165) |  | 56.5% (61/108) | 55.8% (48/86) | |
Location | ||||||
 OSCC | n/a | 50.8% (95/187) |  | n/a | 50.6% (42/83) |  |
 OPSCC | n/a | 23.5% (44/187) |  | n/a | 33.7% (28/83) |  |
 LSCC | n/a | 25.7% (48/187) |  | n/a | 15.7% (13/83) |  |
HPV status | ||||||
 Positive | n/a | 37.9% (25/66) |  | n/a | n/a |  |
 Negative | n/a | 62.1% (41/66) |  | n/a | n/a |  |
Tumor size | ||||||
 T1 | n/a | 24.7% (46/186) |  | n/a | 25.6% (20/78) |  |
 T2 | n/a | 26.3% (49/186) |  | n/a | 33.3% (26/78) |  |
 T3 | n/a | 22.1% (41/186) |  | n/a | 14.1% (11/78) |  |
 T4 | n/a | 26.9% (50/186) |  | n/a | 26.9% (21/78) |  |
Node status | ||||||
 N0 | n/a | 41.9% (78/186) |  | n/a | 36.8% (28/76) |  |
 N1 | n/a | 19.9% (37/186) |  | n/a | 7.9% (6/76) |  |
 N2 | n/a | 35.5% (66/186) |  | n/a | 52.6% (40/76) |  |
 N3 | n/a | 2.7% (5/186) |  | n/a | 2.6% (2/76) |  |
Stage | ||||||
 I | n/a | 18.3%(34/186) |  | n/a | 13.2%(10/76) |  |
 II | n/a | 10.8%(20/186) |  | n/a | 17.1%(13/76) |  |
 III | n/a | 31.7%(59/186) |  | n/a | 22.4%(17/76) |  |
 IV | n/a | 39.3%(73/186) |  | n/a | 47.4%(36/76) |  |